AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Intel caps year from hell with worst-ever stock performance
2
How Lior Wilczynski turned her immigrant roots into a $150 million fintech exit
3
"The most strategic country in the world": Singapore is doubling down on Israeli tech
4
“Israel exits this war more powerful and stable than ever,” says Glilot Capital Partners
5
Nvidia deal delay leads to $200M windfall for Run:ai founders and employees
More news

BiondVax

2 stories about BiondVax
ביונדווקס BiondVax תמר בן ידידיה רון בבקוב

Flu Season Might Soon Pass, for Good

11.12.19|Lilach Baumer
The researchers behind Jerusalem-based BiondVax talked to Calcalist, discussing their potential universal flu vaccine, currently undergoing a phase 3 clinical trial
מריוס נכט 2

Marius Nacht Buys Controlling Stake in Universal Flu Vaccine Developer BiondVax

17.07.19|Micky Grunfeld
Based in Jerusalem, Nasdaq-listed BiondVax develops a universal flu vaccine, currently in advanced clinical trials